The administration of PJ34 reduced the number of cancer cells in developed tumors in mice by up to 90 percent in 30 days, Israeli scientists say.

The company was founded in New York in 2015 by entrepreneurs Eliran Malki, Irad Deutsch and Ohad Rubin, after each lost relatives to cancer.

A new drug treatment regimen in a clinical study at the Sheba Medical Center showed that the disease could be stalled significantly for patients with advanced stages of pancreatic cancer with a BRCA germline mutation.

The Ramat Gan medical center hospital will test and refine the Cocoon system developed by Switzerland’s Lonza Group to fast-track production of CAR-T immunotherapy.

To mark World Cancer Day, NoCamels is highlighting some recent findings in research, clinical trials, detection methods, and new therapies - all from so far this year.

Israeli biotech company Accelerated Evolution Biotechnologies says it developed a cure for all cancers; top scientists and researchers issue warnings.

The Jerusalem-based NewStem, a spinoff of Yissum, The Technology Transfer Company of Hebrew University, raised the seed financing round from a publicly-traded US-based company to be named NovelStem International Corp.

From AI algorithms set to transform diagnoses to new urine and blood tests, these are the cancer-related developments so far this year

The Israeli company is currently developing an artificial intelligence-based system that assists pathologists in the diagnosis of diseases like cancer in a faster and more efficient manner.

Elephants are masters at fighting off cancer. Now a team of Israeli scientists are using elephant genes to fight cancer in humans.

Mediterranean flowers can fight diabetes and cancer, but they also helped in forming an unlikely partnership between Israeli and Palestinian researchers.

Brain surgeons are adopting Israeli flight simulation technology to visualize and prepare for complex micro-surgical procedures in 3D.

Cancer researchers from universities in Israel, America and Britain have come together to create a breakthrough in lung cancer detection that uses a simple and noninvasive breathalyzer test.

One of the reasons why chemotherapy treatments are difficult is because cancer cells are equipped with sophisticated defense mechanisms on their membranes that resist contact from anticancer drugs. Scientists at the Technion studied the complexities of this mechanism to develop a novel therapy strategy they calls the "Pharmacological Trojan Horse".

When an anti-cancer drug is administered in a patient, there is no surefire way to know it'll work – or if the cancer is resistant to it. A new study at the Hebrew University may change that with a way of figuring out if a tumor is resistant beforehand.